BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

726 related articles for article (PubMed ID: 27882374)

  • 21. Outcomes of low-molecular-weight heparin treatment for venous thromboembolism in patients with primary and metastatic brain tumours.
    Chai-Adisaksopha C; Linkins LA; ALKindi SY; Cheah M; Crowther MA; Iorio A
    Thromb Haemost; 2017 Feb; 117(3):589-594. PubMed ID: 28078351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development in anticoagulant therapy.
    van Doormaal FF; Büller HR; Middeldorp S
    Crit Rev Oncol Hematol; 2008 May; 66(2):145-54. PubMed ID: 18032061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of cancer-related thrombosis in the era of direct oral anticoagulants: A comprehensive review of the 2019 ITAC-CME clinical practice guidelines. On behalf of the Groupe Francophone Thrombose et Cancer (GFTC).
    Rafii H; Frère C; Benzidia I; Crichi B; Andre T; Assenat E; Bournet B; Carpentier A; Connault J; Doucet L; Durant C; Emmerich J; Gris JC; Hij A; Le Hello C; Madelaine I; Messas E; Ndour A; Villiers S; Marjanovic Z; Ait Abdallah N; Yannoutsos A; Farge D
    J Med Vasc; 2020 Feb; 45(1):28-40. PubMed ID: 32057323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Venous thromboembolism in cancer patients.
    Deng A; Galanis T; Graham MG
    Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention and treatment of venous thromboembolism during pregnancy.
    Weitz JI
    Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S22-6. PubMed ID: 19213066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimizing the safety of treatment for venous thromboembolism in the era of direct oral anticoagulants.
    Weitz JI; Jaffer IH
    Pol Arch Med Wewn; 2016 Sep; 126(9):688-696. PubMed ID: 27592622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of new anticoagulants for the prevention of venous thromboembolism after major orthopaedic surgery and in hospitalised acutely ill medical patients.
    Ageno W; Spyropoulos AC; Turpie AG
    Thromb Haemost; 2012 Jun; 107(6):1027-34. PubMed ID: 22437976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of venous thromboembolism in patients with cancer: What news from clinical trials?
    Verso M; Franco L; Giustozzi M; Becattini C; Agnelli G
    Thromb Res; 2018 Apr; 164 Suppl 1():S168-S171. PubMed ID: 29703477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of US prescription patterns: Are treatment guidelines for cancer-associated venous thromboembolism being followed?
    Khorana AA; Yannicelli D; McCrae KR; Milentijevic D; Crivera C; Nelson WW; Schein JR
    Thromb Res; 2016 Sep; 145():51-3. PubMed ID: 27485998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Management of Venous Thromboembolism in Cancer Patients].
    Madoiwa S
    Gan To Kagaku Ryoho; 2017 Dec; 44(13):2064-2071. PubMed ID: 29361618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer related venous thromboembolism - prophylaxis and therapy.
    Gary T
    Vasa; 2014 Jul; 43(4):245-51. PubMed ID: 25007902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rethinking the approach to thrombosis in patients with cancer.
    Khorana AA
    Vasc Med; 2020 Jun; 25(3):208-209. PubMed ID: 31718489
    [No Abstract]   [Full Text] [Related]  

  • 33. Non-vitamin K antagonist oral anticoagulants (NOACs) for the management of venous thromboembolism.
    Blann AD; Lip GY
    Heart; 2016 Jun; 102(12):975-83. PubMed ID: 26984888
    [No Abstract]   [Full Text] [Related]  

  • 34. Long Term Low Molecular Weight Heparin Anticoagulant Therapy Modulates Thrombin Generation and D-dimer in Patients with Cancer and Venous Thromboembolism.
    D'Alessio A; Marchetti M; Tartari CJ; Russo L; Cecchini S; Lambregts KWFM; di Mauro D; Falanga A
    Cancer Invest; 2017 Aug; 35(7):490-499. PubMed ID: 28692314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention and Treatment of Venous Thromboembolism in Patients with Cancer: Focus on Drug Therapy.
    van Es N; Bleker SM; Wilts IT; Porreca E; Di Nisio M
    Drugs; 2016 Mar; 76(3):331-41. PubMed ID: 26729187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting recurrent venous thromboembolism in cancer: is it possible?
    Kyrle PA
    Thromb Res; 2014 May; 133 Suppl 2():S17-22. PubMed ID: 24862139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New insights into cancer-associated thrombosis.
    Sousou T; Khorana AA
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):316-20. PubMed ID: 19228604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer-related coagulopathy (Trousseau's syndrome): review of the literature and experience of a single center of internal medicine.
    Dammacco F; Vacca A; Procaccio P; Ria R; Marech I; Racanelli V
    Clin Exp Med; 2013 May; 13(2):85-97. PubMed ID: 23456539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perioperative Venous Thromboembolism: A Review.
    Gordon RJ; Lombard FW
    Anesth Analg; 2017 Aug; 125(2):403-412. PubMed ID: 28640782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary venous thromboembolism prophylaxis in ambulatory cancer patients.
    Aikens GB; Rivey MP; Hansen CJ
    Ann Pharmacother; 2013 Feb; 47(2):198-209. PubMed ID: 23386067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.